Predicting 15-year prostate cancer specific mortality after radical prostatectomy

Journal of Urology

Volumn 185, Issue 3, 2011, Pages 869-875

  Eggener, Scott E ^a   Scardino, Peter T ^b   Walsh, Patrick C ^c   Han, Misop ^c   Partin, Alan W ^c   Trock, Bruce J ^c   Feng, Zhaoyong ^c   Wood, David P ^d   Eastham, James A ^b   Yossepowitch, Ofer ^e   Rabah, Danny M ^f   Kattan, Michael W ^g   Yu, Changhong ^g   Klein, Eric A ^g   Stephenson, Andrew J ^g  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e RABIN MEDICAL CENTER   (Israel)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g LERNER RESEARCH INSTITUTE   (United States)

Author keywords

mortality; nomograms; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; EXTERNAL VALIDITY; FOLLOW UP; GLEASON SCORE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; SEMINAL VESICLE;

AGED; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 79851513695     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.10.057     Document Type: Article

References (25)

1. A. Bill-Axelson, L. Holmberg, and F. Filen Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 2008 1144
2. G. Draisma, R. Etzioni, and A. Tsodikov Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context J Natl Cancer Inst 101 2009 374
3. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005
4. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1999 1499
5. A.J. Stephenson, M.W. Kattan, and J.A. Eastham Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era J Clin Oncol 27 2009 4300
6. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual American Joint Committee on Cancer 6th ed. 2002 Springer-Verlag New York
7. F. Dong, A.M. Reuther, and C. Magi-Galluzzi Pathologic stage migration has slowed in the late PSA era Urology 70 2007 839
8. P.C. Albertsen, J.A. Hanley, and J. Fine 20-Year outcomes following conservative management of clinically localized prostate cancer JAMA 293 2005 2095
9. J. Cuzick, G. Fisher, and M.W. Kattan Long-term outcome among men with conservatively treated localised prostate cancer Br J Cancer 95 2006 1186
10. C. Parker, D. Muston, and J. Melia A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival Br J Cancer 94 2006 1361
11. J.I. Epstein, W.C. Allsbrook Jr, and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228
12. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
13. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956
14. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433
15. A.V. D'Amico, J.W. Moul, and P.R. Carroll Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Natl Cancer Inst 95 2003 1376
16. P. Zhou, M.H. Chen, and D. McLeod Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Clin Oncol 23 2005 6992
17. T.H. Van derKwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178
18. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325
19. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760
20. A.J. Vickers, F.J. Bianco, and A.M. Serio The surgical learning curve for prostate cancer control after radical prostatectomy J Natl Cancer Inst 99 2007 1171
21. P.C. Albertsen, J.A. Hanley, and G.H. Barrows Prostate cancer and the Will Rogers phenomenon J Natl Cancer Inst 97 2005 1248
22. C.R. Porter, K. Kodama, and R.P. Gibbons 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series J Urol 176 2006 569
23. J.E. Johansson, O. Andren, and S.O. Andersson Natural history of early, localized prostate cancer JAMA 291 2004 2713
24. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
25. A.V. D'Amico, M.H. Chen, and K.A. Roehl Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy N Engl J Med 351 2004 125